SCHEMBL18116276

SCHEMBL18116276

N#CCC(=O)c1ccc(OCCF)cc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.47
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPC1 O15118 1/20 0.42
MMP1 P03956 1/20 0.42
CYP19A1 P11511 1/20 0.42
MMP2 P08253 2/20 0.42
GAA P10253 2/20 0.41
RAB9A P51151 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP13 P45452 1/20 0.41
PKM P14618 1/20 0.41
THRA P10827 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18551705 0.84 L3MBTL1 (0.59) MAPTL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL4859516 0.80 NPC1 (0.62) MAPTL3MBTL1ALDH1A1KMT2ANPC1
SCHEMBL3595754 0.79 RAB9A (0.47) MAPTL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL395103 0.78 GSK3B (0.48) MAPTL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL5745992 0.78 GSK3B (0.58) MAPTL3MBTL1ALDH1A1NPC1MMP1
SCHEMBL9736095 0.76 NPC1 (0.48) MAPTL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL135620 0.76 HDAC3 (0.59) MAPTALDH1A1NPC1MMP1RAB9A
SCHEMBL1879154 0.75 PKM (0.69) L3MBTL1ALDH1A1GAAPKM
SCHEMBL2092444 0.75 HTT (0.55) L3MBTL1ALDH1A1MEN1KMT2ANPC1
SCHEMBL136576 0.75 MMP2 (0.47) MAPTALDH1A1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458161-B1 TSPO ligands for cancer imaging and treatment VANDERBLIT UNIVERSITY (US) 2016-10-04 US disclosed
US-9458161-B1 TSPO ligands for cancer imaging and treatment VANDERBLIT UNIVERSITY (US) 2016-10-04 US disclosed